

Parmax Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 3.74 Cr
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.72 Cr
- Satisfied Charges ₹ 8.24 Cr
- Revenue Growth -15.56%
- Profit Growth -173.54%
- Ebitda -11.90%
- Net Worth -1.75%
- Total Assets -2.01%
About Parmax Pharma
Parmax Pharma Limited (PPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 02 November 1994 and has a history of 30 years and four months. Its registered office is in Rajkot, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540359.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.74 Cr.
The company currently has active open charges totaling ₹6.72 Cr. The company has closed loans amounting to ₹8.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Parmax Pharma Limited India are Bhakti Aghera as COMPANY SECRETARY and Keyur Vora as Cfo. Nikhil Uchat, Ami Rajeshbhai, and Umang Gosalia serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24231GJ1994PLC023504
- Company No.
023504
- Stock Symbol
BSE : 540359
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Nov 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Parmax Pharma?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umang Gosalia ![]() | Managing Director | 02-Jan-2016 | Current |
Bhakti Aghera ![]() | Company Secretary | 17-May-2024 | Current |
Keyur Vora ![]() | CFO | 02-Jan-2016 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ami Rajeshbhai ![]() | Director | 17-Jun-2018 | Current |
Nikhil Uchat ![]() | Director | 25-Apr-2023 | Current |
Financial Performance of Parmax Pharma.
Parmax Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.56% decrease. The company also saw a substantial fall in profitability, with a 173.54% decrease in profit. The company's net worth dipped by a decrease of 1.75%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Parmax Pharma?
In 2021, Parmax Pharma had a promoter holding of 30.80% and a public holding of 69.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Malwin Pharma Private Limited
Umang Gosalia is a mutual person
Charges (Loans)
₹6.72 Cr
₹8.24 Cr
Charges Breakdown by Lending Institutions
- Others : 6.72 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
31 May 2023 | Others | ₹6.72 Cr | Open |
08 Feb 2019 | Hdfc Bank Limited | ₹1.12 Cr | Satisfied |
16 Oct 2018 | Hdfc Bank Limited | ₹6.85 Cr | Satisfied |
28 Jul 2017 | Hdfc Bank Limited | ₹2.67 M | Satisfied |
How Many Employees Work at Parmax Pharma?
Parmax Pharma has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Parmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parmax Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Parmax Pharma
Recent activity within the organization
- Annual General Meeting
Parmax Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Director Appointment
Bhakti Rameshbhai Aghera was appointed as a Company Secretary was appointed as a Company Secretary on 17 May 2024 & has been associated with this company since 9 months 26 days .
- Balance Sheet
Parmax Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Charges
A charge with Others of Rs. 6.72 Cr registered on 31 May 2023 with Charge ID 100775935 was modified on 10 Nov 2023.
- Charges
A charge registered on 08 Feb 2019 via Charge ID 100240259 with Hdfc Bank Limited was fully satisfied on 16 Oct 2023.
- Charges
A charge registered on 16 Oct 2018 via Charge ID 100215130 with Hdfc Bank Limited was fully satisfied on 16 Oct 2023.
Recent News, Updates & Announcement
- Parmax Pharma's Quarterly Numbers Show Impressive Growth in Sales, Profits, EBITDA, and EPS - Stock Price on the Rise.
Parmax Pharma's quarterly numbers are looking good, with a big increase in sales and profits. EBITDA is also up by a crazy amount. EPS has gone up too. Their stock price has gone up a bit, but it's still down from last year. Overall, things are looking up for Parmax Pharma. #winning #pharmalife.
Frequently asked questions
What is the Incorporation or founding date of Parmax Pharma Limited?
Parmax Pharma Limited was incorporated on 02 Nov 1994.
What is authorized share capital and paid-up capital of Parmax Pharma Limited?
The authorized share capital of Parmax Pharma Limited is ₹ 6.00 Cr and paid-up capital is ₹ 3.74 Cr.
Who are the current board members & directors of Parmax Pharma Limited?
Currently 5 directors are associated with Parmax Pharma Limited.
- Bhakti Rameshbhai Aghera
- Keyur Dineshbhai Vora
- Nikhil Sureshchandra Uchat
- Ami Shah Rajeshbhai
- Umang Alkesh Gosalia
What is the registered address of Parmax Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Parmax Pharma Limited is Plot No. 20 Survey 52 Rajkot-Gondal National Highway 27, India, Hadamtala, Gujarat, 360311.
What is the corporate identification number (CIN) and company number of Parmax Pharma Limited?
The corporate identification number (CIN) of Parmax Pharma Limited is L24231GJ1994PLC023504 and the company number is 023504 as per Ministry of Corporate Affairs (MCA).
Is Parmax Pharma Limited registered with any stock exchange in India?
Yes, Parmax Pharma Limited is registered on Bombay Stock Exchange (BSE).
What is the official website of Parmax Pharma Limited?
The Official website of Parmax Pharma Limited is https://www.parmaxpharma.com
What has been the recent revenue trend for Parmax Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Parmax Pharma Limited has fallen by -15.56%.
How many employees does Parmax Pharma Limited currently have?
As Per 2023 financial reports, 9 employees are currently employed by Parmax Pharma Limited.
What change has been observed in the net worth of Parmax Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Parmax Pharma Limited has experienced an downturn of -1.75%.
What are the total open charges for Parmax Pharma Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Parmax Pharma Limited amount to ₹ 6.72 Cr.
When was the last Balance Sheet of Parmax Pharma Limited filed with the ROC?
The most recent Balance Sheet for Parmax Pharma Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
PC
Pramay ChhatraDirectorAG
Alkesh GosaliaManaging DirectorJD
Jayantilal DholManaging DirectorAG
Alkesh GopaniManaging DirectorMJ
Mansukhbhai JivaniDirectorPP
Prabhudas PatelDirectorVG
Vipul GopaniDirectorMG
Mahasukh GopaniDirector